Screening for Asymptomatic Bacteriuria in Adults

Abstract

Background: The literature surrounding the screening for asymptomatic bacteriuria (ASB) in adults has evolved significantly over the past decade, reflecting changing perspectives on the necessity and efficacy of such practices. Literature Review: This perspective is supported by evidence suggesting that many individuals with ASB do not benefit from treatment, challenging historical practices that favored over-treatment (E. Nicolle, 2016). The need for antenatal screening remains critical, especially in low-resource settings, where untreated ASB can lead to severe complications during pregnancy (Gehani et al., 2019). Research examining urine testing practices in community health systems reinforces the recommendation against routine screening and treatment of ASB in asymptomatic adults (Brenneman et al., 2021). This study highlights the potential overuse of diagnostic testing and calls for a more judicious approach to urine culture and analysis, aligning with the growing consensus to limit unnecessary medical interventions (Brenneman et al., 2021). Further critical assessments of ASB screening in pregnant women reveal a lack of robust data linking ASB to adverse perinatal outcomes, suggesting that current screening practices may not be justified by the evidence (Hernández-Hernández et al., 2022). Conclusion: There is a clear trend towards more selective screening practices, particularly emphasizing the importance of targeted interventions for vulnerable populations, such as pregnant women. The need for further research to clarify the implications of ASB treatment, especially in non-pregnant adults, remains vital to inform clinical guidelines and improve patient outcomes.